Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol.
Saved in:
| Title: | Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol. |
|---|---|
| Authors: | Freet CS; Penn State College of Medicine., Shuler K; Penn State College of Medicine., Kawasaki S; Penn State College of Medicine., Weintraub E; University of Maryland School of Medicine., Greenblatt A; University of Maryland School of Medicine., Kladney M; New York University Grossman School of Medicine., Nunes E; Columbia University Irving Medical Center., Foster KL; National Institute on Drug Abuse., Kong L; Penn State College of Medicine., Raja-Khan N; Penn State College of Medicine., Cleveland HH; Pennsylvania State University., Grigson PS; Penn State College of Medicine., Bunce SC; Penn State College of Medicine., Brick TR; Pennsylvania State University., Nyland JE; Penn State College of Medicine. |
| Source: | Research square [Res Sq] 2025 May 26. Date of Electronic Publication: 2025 May 26. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40502777 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Freet+CS%22">Freet CS</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Shuler+K%22">Shuler K</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Kawasaki+S%22">Kawasaki S</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Weintraub+E%22">Weintraub E</searchLink>; University of Maryland School of Medicine.<br /><searchLink fieldCode="AU" term="%22Greenblatt+A%22">Greenblatt A</searchLink>; University of Maryland School of Medicine.<br /><searchLink fieldCode="AU" term="%22Kladney+M%22">Kladney M</searchLink>; New York University Grossman School of Medicine.<br /><searchLink fieldCode="AU" term="%22Nunes+E%22">Nunes E</searchLink>; Columbia University Irving Medical Center.<br /><searchLink fieldCode="AU" term="%22Foster+KL%22">Foster KL</searchLink>; National Institute on Drug Abuse.<br /><searchLink fieldCode="AU" term="%22Kong+L%22">Kong L</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Raja-Khan+N%22">Raja-Khan N</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Cleveland+HH%22">Cleveland HH</searchLink>; Pennsylvania State University.<br /><searchLink fieldCode="AU" term="%22Grigson+PS%22">Grigson PS</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Bunce+SC%22">Bunce SC</searchLink>; Penn State College of Medicine.<br /><searchLink fieldCode="AU" term="%22Brick+TR%22">Brick TR</searchLink>; Pennsylvania State University.<br /><searchLink fieldCode="AU" term="%22Nyland+JE%22">Nyland JE</searchLink>; Penn State College of Medicine. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101768035%22">Research square</searchLink> [Res Sq] 2025 May 26. <i>Date of Electronic Publication: </i>2025 May 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101768035 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2693-5015 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226935015%22">26935015 </searchLink><i>NLM ISO Abbreviation: </i>Res Sq <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40502777 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21203/rs.3.rs-6666196/v1 Languages: – Code: eng Text: English Titles: – TitleFull: Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Freet CS – PersonEntity: Name: NameFull: Shuler K – PersonEntity: Name: NameFull: Kawasaki S – PersonEntity: Name: NameFull: Weintraub E – PersonEntity: Name: NameFull: Greenblatt A – PersonEntity: Name: NameFull: Kladney M – PersonEntity: Name: NameFull: Nunes E – PersonEntity: Name: NameFull: Foster KL – PersonEntity: Name: NameFull: Kong L – PersonEntity: Name: NameFull: Raja-Khan N – PersonEntity: Name: NameFull: Cleveland HH – PersonEntity: Name: NameFull: Grigson PS – PersonEntity: Name: NameFull: Bunce SC – PersonEntity: Name: NameFull: Brick TR – PersonEntity: Name: NameFull: Nyland JE IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 05 Text: 2025 May 26 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2693-5015 Titles: – TitleFull: Research square Type: main |
| ResultId | 1 |
